Last SFr.81.10 CHF
Change Today +0.25 / 0.31%
Volume 3.5M
NOVN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
Frankfurt
SIX Swiss Ex
As of 11:45 AM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan R. Symonds CBE

Deputy Chief Financial Officer, Novartis Vaccines and Diagnostics, Inc.
AgeTotal Calculated CompensationThis person is connected to 58 board members in 5 different organizations across 11 different industries.

See Board Relationships
55--

Background*

Mr. Jonathan R. Symonds, also known as Jon, C.B.E. has been the Chief Financial Officer at Novartis Institutes for BioMedical Research, Inc. since September 1, 2009. Mr. Symonds serves as Deputy Chief Financial Officer at Novartis Vaccines and Diagnostics, Inc. He served as the Chief Financial Officer of Novartis AG from 2010 to May 1, 2013. Mr. Symonds served as an Advisor of Novartis AG since May 1, 2013. He was a Partner and Managing Director of Goldman Sachs from ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Director
Former Director
1997-2007
Former Chief Financial Officer and Executive Director
2004-2007
Former Non Executive Director, Chairman of Audit Committee, Member of Nomination Committee and Member of Remuneration Committee
2014-Present
Independent Non-Executive Director, Member of Group Remuneration Committee and Member of Conduct & Values Committee
2014-Present
Chairman
2014-Present
Director

Education*

BA 1980
University of Hertfordshire

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.81.10 CHF +0.25

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.